ACR Basic & Clinical Research Conference: Disrupting the Genetics of Rheumatology: The Role of Somatic Mutations in Health and Disease

ACR基础

• 批准号: 10540583
• 负责人: Kristine A. Kuhn
• 金额: $ 6万
• 依托单位: AMERICAN COLLEGE OF RHEUMATOLOGY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2027-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10540583
• 关键词: Advocacy; Affect; American; Arthritis; Basic Science; Biology; Characteristics; Clinical; Clinical Research; Clinical Services; Colorado; Communities; Degenerative polyarthritis; Department chair; Development; Discipline; Disease; Education; Epidemiology; Event; Evolution; Fostering; Genetic; Genome; Goals; Grant; Head; Health; Health Services Research; Healthcare; Human; Immunology; Immunotherapeutic agent; Investigation; Israel; Knowledge; Laboratories; Medical; Medical Research; Medical center; Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Oral; Pain; Participant; Patient Care; Patients; Persons; Physiology; Practice Management; Public Health; Public Health Schools; Research; Research Institute; Research Personnel; Research Training; Resources; Rheumatism; Rheumatology; Role; Schedule; Scientist; Somatic Mutation; Spondylarthritis; Time; Training; Translating; Translational Research; Underrepresented Minority; United States National Institutes of Health; Universities; chronic pain; clinical practice; college; coronavirus disease; cost; genetic epidemiology; improved; insight; interest; meetings; mid-career faculty; novel therapeutics; professor; programs; symposium; virtual

Project Summary-Abstract The American College of Rheumatology (ACR) has been a leader in the effort to facilitate the bidirectional exchange of cutting-edge scientific information between scientists and investigators in rheumatic diseases through its annual Basic and Clinical Research Conferences. The ACR has successfully hosted the conference as separate programs and as a combined basic science and clinical research program, as well as both in- person and virtually. Each program has been held in conjunction with ACR’s annual meeting, Convergence. The ACR annual meeting, ACR Convergence, attracts between 10,000 and 15,000 attendees each year and is the principal mechanism for providing a forum for the exchange of ideas about research, education, patient care, practice management and advocacy issues. Because the Basic and Clinical Research Conferences have been held in conjunction with ACR Convergence, typically as a pre-meeting event, ACR has been able to attract renown scientists and investigators who may otherwise not have attended. For 2022, the Basic and Clinical Research Conference will be held jointly to attract scientists and investigators from both the basic, clinical and translational research communities. The tentative title of the conference is Disrupting the Genetics of Rheumatology: The Role of Somatic Mutations in Health and Disease . This combined approach will focus on the role of somatic mutations in the development rheumatologic diseases. Clinical research sessions will focus on genetic epidemiology approaches for associating somatic mutations with disease. Basic research sessions will explore topics such as identification of the presence and functional role of somatic mutations. The conference organizers include Dr. Jill Norris, Professor and Chair of the Department of Epidemiology at the Colorado School of Public Health; Dr. Peter Grayson, Earl Stadtman Investigator at the NIAMS; Dr. Linda Hiraki, ACR Committee on Research Liaison, Clinician-Scientist in the Division of Rheumatology and Scientist in Genetics & Genome Biology at SickKids Research Institute; Dr. Iannis Adampopoulos, ACR Committee on Research Liaison, Director of the Arthritis Program and Head of Osteoimmunity Laboratory at the Beth Israel Deaconess Medical Center; and Dr. Kristine Kuhn, ACR Committee on Research Chair and Associate Professor of Medicine-Rheumatology at the University of Colorado and the Co-Director of the University of Colorado Program for Advancing Spondyloarthritis Treatment. The ACR Committee on Research focuses on research and research training in rheumatology and encourages clinical and health services research on the organization of medical and health care as they may affect patients with rheumatic diseases.

项目摘要-摘要 美国流变学学院（ACR）一直是促进双向交流的领导者。 风湿病科学家和研究人员之间的前沿科学信息交流 通过其年度基础和临床研究会议。ACR成功举办了这次会议 作为单独的计划，并作为一个综合的基础科学和临床研究计划，以及在- 人和虚拟。每个项目都与ACR的年会“融合”一起举行。 ACR年度会议ACR Convergence每年吸引10，000至15，000名与会者， 为研究、教育、病人和医疗服务提供交流意见的主要机制。 护理、实践管理和宣传问题。因为基础和临床研究会议 与ACR Convergence一起举行，通常作为会前活动，ACR能够 吸引了那些本来可能不会参加的著名科学家和研究人员。 2022年，基础和临床研究会议将联合举行，以吸引科学家和研究人员 来自基础、临床和转化研究界。会议的暂定名称是 扰乱流变学的遗传学：体细胞突变在健康和疾病中的作用。这 联合的方法将集中于体细胞突变在风湿性疾病发展中的作用。 临床研究会议将集中在遗传流行病学方法相关联的体细胞突变 疾病。基础研究会议将探讨主题，如识别的存在和功能 体细胞突变的作用。 会议组织者包括吉尔诺里斯博士，教授和流行病学系主任， 科罗拉多公共卫生学院; NIAMS的Earl Stadtman研究员Peter Grayson博士;琳达博士 Hiraki，ACR研究联络委员会，流变学和科学家部门的临床医生-科学家 SickKids研究所遗传学和基因组生物学; Iannis Adampopoulos博士，ACR委员会 研究联络员，贝斯以色列关节炎项目主任和骨免疫实验室负责人 Deaconess医疗中心;和Kristine Kuhn博士，ACR研究委员会主席和助理 科罗拉多大学医学-流变学教授， 科罗拉多脊柱关节炎治疗进展计划。ACR研究委员会专注于 在风湿病学的研究和研究培训，并鼓励临床和卫生服务的研究， 医疗和保健组织，因为它们可能影响风湿病患者。